According to
GuruFocus Insider Data
, these are the largest CEO buys during the past week. The
overall trend of CEOs is illustrated in the chart below:
Synta Pharmaceuticals Corp. (
SNTA
): President and CEO Safi R Bahcall Bought 10,000 Shares
President and CEO of Synta Pharmaceuticals Corp. (
SNTA
) Safi R Bahcall bought 10,000 shares on 06/29/2012 at an average
price of $6.53. SYNTA PHARMACEUTICALS CORP. is a
biopharmaceutical company focused on discovering, developing, and
commercializing small molecule drugs to extend and enhance the
lives of patients with severe medical conditions, including
cancer and chronic inflammatory diseases. Synta Pharmaceuticals
Corp. has a market cap of $315.3 million; its shares were traded
at around $6.53 with and P/S ratio of 41.6.
Synta recently reported its first quarter 2012 financial results.
Total revenue was $0.1 million for the first quarter in 2012
compared to total revenue of $1.1 million for the same period in
2011. The Company reported a net loss of $15.1 million or
$0.27per basic and diluted share for the first quarter in 2012,
compared to a net loss of $11.4 million, or $0.27 per basic and
diluted share for the same period in 2011.
Jean-Marie Eveillard
bought 200,000 shares in the quarter that ended on 03/31/2012,
which is 0.0035% of the $25.09 billion portfolio of First Eagle
Investment Management, LLC.
VP, Fin. and Admin., CFO
Keith S Ehrlich
sold 4,397 shares of SNTA stock on 03/01/2012 at the average
price of 4.7. Keith S Ehrlich owns at least 17,573 shares after
this. The price of the stock has increased by 38.94% since. There
are mixed trades from other insiders.
Methode Electronics Inc. (
MEI
): CEO Donald W Duda Bought 3,860 Shares
CEO of Methode Electronics Inc. (
MEI
) Donald W Duda bought 3,860 shares on 07/02/2012 at an average
price of $8.5. Methode Electronics, Inc. manufactures component
devices world-wide for Original Equipment Manufacturers of
information processing and networking equipment, voice and data
communications systems, consumer electronics, automobiles,
aerospace vehicles and industrial equipment. Methode Electronics
Inc. has a market cap of $315.3 million; its shares were traded
at around $8.5 with a P/E ratio of 35.5 and P/S ratio of 0.7. The
dividend yield of Methode Electronics Inc. stocks is 3.3%.
Methode Electronics recently reported its fiscal fourth quarter
2012 financial results. Net income decreased $4.3 million to $5.8
million, or $0.15 per share, in the fourth quarter of Fiscal 2012
from net income of $10.1 million, or $0.27 per share, in the same
period of Fiscal 2011.
NWQ Managers
bought 841,445 shares in the quarter that ended on 03/31/2012,
which is 0.052% of the $14.95 billion portfolio of NWQ Investment
Management Co. James Barrow owns 774,500 shares as of 03/31/2012,
which accounts for 0.014% of the $50.84 billion portfolio of
Barrow, Hanley, Mewhinney & Strauss. Mario Gabelli owns
210,500 shares as of 03/31/2012, which accounts for 0.014% of the
$13.95 billion portfolio of GAMCO Investors.
CFO Douglas A Koman bought 3,616 shares of MEI stock on
07/02/2012 at the average price of 7.95. Douglas A Koman owns at
least 199,042 shares after this. The price of the stock has
increased by 6.92% since. Other insiders have also increased
their positions in the company.
Paramount Gold and Silver Corp. (
PZG
): CEO Christopher Crupi Bought 10,000 Shares
CEO of Paramount Gold and Silver Corp. (
PZG
) Christopher Crupi bought 10,000 shares on 06/28/2012 at an
average price of $2.4. Paramount Gold and Silver Corp. engages in
the acquisition, exploration, and development of gold, silver,
and precious metal properties primarily in Mexico. Paramount Gold
And Silver Corp. has a market cap of $353.8 million; its shares
were traded at around $2.4 with and P/S ratio of 1179.6.
CFO Carlo Buffone bought 20,000 shares of PZG stock on 03/29/2012
at the average price of 2.2. Carlo Buffone owns at least 20,000
shares after this. The price of the stock has increased by 9.09%
since. Other insiders have also increased their positions in the
company.
Marchex, Inc. (
MCHX
): CEO, 10% Owner Russell C Horowitz Bought 5,000 Shares
CEO, 10% Owner of Marchex, Inc. (
MCHX
) Russell C Horowitz bought 5,000 shares on 07/03/2012 at an
average price of $3.93. Marchex Inc provides technology-based
services to merchants engaged in online transactions. Marchex,
Inc. has a market cap of $134.3 million; its shares were traded
at around $3.93 with a P/E ratio of 361.1 and P/S ratio of 0.9.
The dividend yield of Marchex, Inc. stocks is 2.2%.
CFO Michael A Arends bought 1,500 shares of MCHX stock on
05/18/2012 at the average price of 3.26. Michael A Arends owns at
least 482,500 shares after this. The price of the stock has
increased by 20.55% since. There are mixed trades from other
insiders.
Cytomedix, Inc. (
CMXI
): CEO Martin P Rosendale Bought 8,000 Shares
CEO of Cytomedix, Inc. (
CMXI
) Martin P Rosendale bought 8,000 shares on 07/03/2012 at an
average price of $1.35. Cytomedix, Inc. is a biotechnology
company specializing in the research, development, licensing, and
distribution of systems for autologous cellular therapies.
Cytomedix, Inc. has a market cap of $106.7 million; its shares
were traded at around $1.35 with and P/S ratio of 14.7.
Cytomedix recently reported its first quarter 2012 financial
results. Total revenues increased 121% to $3.02 million from
$1.37 million. Product sales increased 23% to $1.69 million from
$1.37 million.
CFO Andrew Scott Maslan bought 5,000 shares of CMXI stock on
07/03/2012 at the average price of 1.08. Andrew Scott Maslan owns
at least 102,780 shares after this. The price of the stock has
increased by 25% since.
For the complete list of stocks that bought by their company
CEOs, go to: CEO Buys.About GuruFocus: GuruFocus.com tracks the
stocks picks and portfolio holdings of the world's best
investors. This value investing site offers stock screeners and
valuation tools. And publishes daily articles tracking the latest
moves of the world's best investors. GuruFocus also provides
promising stock ideas in 3 monthly newsletters sent to
Premium Members
.